https://www.selleckchem.com/products/abt-199.html
001, respectively), especially postoperative complications in stage III patients ( .001) and severe complications in stages II and III patients ( =.024 and =.004, respectively). In addition, a low ALI was an independent predictor of a poor overall survival (hazard ratio 2.30, 95% confidence interval 1.52-3.50, .001) and relapse-free survival (hazard ratio 1.73, 95% confidence interval 1.22-2.44, =.002), especially in older patients, and in patients without lymph node metastasis or severe postoperative complications. This study s
Gefällt mir
Kommentar
Teilen
